The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy
Open accessAbstract
The use of complementary medicines, such as plant extracts, in dementia therapy varies according to the different cultural traditions. In orthodox Western medicine, contrasting with that in China and the Far East for example, pharmacological properties of traditional cognitive- or memory-enhancing plants have not been widely investigated in the context of current models of Alzheimer's disease. An exception is Gingko biloba in which the gingkolides have antioxidant, neuroprotective and cholinergic activities relevant to Alzheimer's disease mechanisms. The therapeutic efficacy of Ginkgo extracts in Alzheimer's disease in placebo controlled clinical trials is reportedly similar to currently prescribed drugs such as tacrine or donepezil and, importantly, undesirable side effects of Gingko are minimal. Old European reference books, such as those on medicinal herbs, document a variety of other plants such as Salvia officinalis (sage) and Melissa officinalis (balm) with memory-improving properties, and cholinergic activities have recently been identified in extracts of these plants. Precedents for modern discovery of clinically relevant pharmacological activity in plants with long-established medicinal use include, for example, the interaction of alkaloid opioids in Papaver somniferum (opium poppy) with endogenous opiate receptors in the brain. With recent major advances in understanding the neurobiology of Alzheimer's disease, and as yet limited efficacy of so-called rationally designed therapies, it may be timely to re-explore historical archives for new directions in drug development. This article considers not only the value of an integrative traditional and modern scientific approach to developing new treatments for dementia, but also in the understanding of disease mechanisms. Long before the current biologically-based hypothesis of cholinergic derangement in Alzheimer' s disease emerged, plants now known to contain cholinergic antagonists were recorded for their amnesia- and dementia-inducing properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, there are a plethora of other medicinal plants that show preventative and therapeutic activity for AD [174].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [174]
Citations
Cites
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., & Hörr, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979544 · Cited by 369
Ginkgo biloba for cerebral insufficiency.
Kleijnen, J., & Knipschild, P. G. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb05642.x · Cited by 339
Perry, E. K., & Perry, R. H. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1255 · Cited by 277
Self-citationSmith, P. F., Maclennan, K., & Darlington, C. L. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(96)01379-7 · Cited by 263
Schliebs, R., Liebmann, A., Bhattacharya, S. K., Kumar, A., GHOSAL, S., & Bigl, V. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00025-3 · Cited by 219
Smoking and Alzheimer's Disease: A Review of the Epidemiological Evidence
Lee, P. N. (1994) · Neuroepidemiology · doi:10.1159/000110372 · Cited by 209
Inhibition of Acetylcholinesterase Activity by Monoterpenoids with a p-Menthane Skeleton
Miyazawa, M., Watanabe, H., & Kameoka, H. (1997) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf960398b · Cited by 208
Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root
Lim, J.-H., Wen, T.-C., Matsuda, S., Tanaka, J., Maeda, N., Peng, H., Aburaya, J., Ishihara, K., & Sakanaka, M. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(97)00041-2 · Cited by 185
Park, C., Kim, S., Choi, W., Lee, Y. J., Kim, J., Kang, S. S., & Sun, Y. (1996) · Planta Medica · doi:10.1055/s-2006-957926 · Cited by 143
Research works printed but not linked: 14
- Bhattacharya, 1995, Effect of MentatR, a herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats, Fitoterapia, 66, 216
- Burkard, 1991, Verhaltnis Von demenzen vom multinfarkt und vom Alzheimertyp in arzlichen praxen. Diagnostische und Therapeutische Konsequenzen am beispiel eines Ginkgobiloba praparates, Munch. Med. Wschr., 133, 38
- Coghan, 1584, The Haven of Health
- Culpeper, 1652, Culpeper's Complete Herbal: consisting of a comprehensive description of nearly all herbs with their medicinal properties
- Evelyn, 1699, Acetaria
- Everard, 1659, Panacea or the Universal Medicine
- Gerard, 1876, A catalogue of Plants (1596-1599)
- Grieve, 1931, A Modern Herbal
- Hill, 1755, The Family Herbal
- Hwang, 1996, An acetylcholinesterase inhibitor isolated from corydalis tuber and its mode of action, Korean J. Pharmacog., 27, 91
- McIntyre, 1996, The Complete Floral Healer
- Mitchell, 1993, Aromatherapy's effectiveness in disorders associated with dementia, Int. J. Aromatherapy, 5, 20
- Taylor, 1986, Neuromediator binding to receptors in the rat brain, The effect of chronic administration of Ginkgo biloba extract. Presse Medicale-Paris, 15, 1491
- Xu, 1995, Efficacy of tablet huperzine-A on memory, cognition and behaviour in Alzheimer's disease, Chung-Kuo Yao Li Hsueh Pao-Acta Pharmacologica Sinica, 16, 391
Cited by
Sorted by citations
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Antioxidant Activity and Total Phenolic Content of Moringa oleifera Leaves in Two Stages of Maturity
Sreelatha, S., & Padma, P. R. (2009) · Plant Foods for Human Nutrition · doi:10.1007/s11130-009-0141-0 · Cited by 693
Pharmacological properties of Salvia officinalis and its components
Ghorbani, A., & Esmaeilizadeh, M. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.12.014 · Cited by 677
Ferreira, A., Proença, C., Serralheiro, M. L. M., & Araújo, M. E. M. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.04.010 · Cited by 480
The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils
Zhu, M., Rajamani, S., Kaylor, J. J., Han, S., Zhou, F., & Fink, A. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403129200 · Cited by 480
Metadata
- Authors
- Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., & Perry, N. S. L.
- Affiliations
- Medical Research Council (GB)
- Newcastle University (GB)
- King's College London (GB)
- Corresponding author
- Perry, Elaine K
- ORCID
- Wang, Wei Wei
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05-01
- Volume
- 51
- Issue
- 5
- Pages
- 527-534
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W1997343208
- Cited by
- 285
- References
- 45
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 14 · 2023: 14 · 2022: 9 · 2021: 13 · 2020: 12 · 2019: 13 · 2018: 15 · 2017: 13 · 2016: 8 · 2015: 7 · 2014: 17 · 2013: 12 · 2012: 10
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Pharmacy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
- Keywords
- Alzheimer's disease, medicinal plants, ethnobotany, herbal medicine, Ginkgo biloba, cholinergic activity, Salvia officinalis, lemon balm, memory enhancement, traditional medicine, dementia, drug development, cholinergic hypothesis, neuroprotection, antioxidant activity
- MeSH terms
- Alzheimer Disease, China, Dementia, Humans, Medicine, Chinese Traditional, Phytotherapy, Plants, Medicinal, Saliva, Cholinergic Agents, Ethnobotany, Ginkgo biloba
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
